Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Operating and Financial Results
City of Hope, a leader in cancer research and treatment, was awarded $5.3 million from California Institute for Regenerative Medicine (CIRM) to develop a treatment... Read more.
OFS Credit Company Provides February 2024 Net Asset Value Update
CHICAGO–(BUSINESS WIRE)–OFS Credit Company, Inc. (NASDAQ: OCCI) (“OFS Credit”, the “Company”, “we”, “us”... Read more.
California University of Science and Medicine Celebrates Match Day for 2024 MD Graduates
Nearly 80 percent to join residency programs in California; 33 percent in the Inland Empire COLTON, Calif.–(BUSINESS WIRE)–California University of Science... Read more.
KBRA Assigns AA Rating, Stable Outlook to State of Louisiana General Obligation Bonds Series 2024-A and Refunding Series 2024-B; Affirms Rating for Parity Bonds
NEW YORK–(BUSINESS WIRE)–#creditratingagency–KBRA assigns a long-term rating of AA with a Stable Outlook to the State of Louisiana General Obligation... Read more.
AM Best to Participate in Panel Discussion at Annual IFRS 17 Conference in London
LONDON–(BUSINESS WIRE)–#insurance—AM Best will participate in a panel discussion at the annual IFRS 17 Conference, hosted by InsuranceERM, to be... Read more.
MeridianLink Inc. (MLNK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK–(BUSINESS WIRE)–$MLNK #classaction–Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC is investigating potential claims... Read more.
Revitalizing a 71-mile Gem: High Line Canal Conservancy Unveils Great Lengths Campaign Following GOCO Award
DENVER–(BUSINESS WIRE)–Today, the High Line Canal Conservancy announces Great Lengths for the High Line, a $33 million campaign poised to revitalize... Read more.
CARVYKTI® (ciltacabtagene autoleucel) Receives Recommendation from the U.S. FDA Oncologic Drugs Advisory Committee for Earlier Treatment of Patients with Relapsed/Refractory Multiple Myeloma
FDA ODAC votes 11 to 0 supporting favorable risk-benefit assessment of CARVYKTI based on results from the Phase 3 CARTITUDE-4 study SOMERSET, N.J.–(BUSINESS... Read more.
Farmers Edge Shareholders Approve Plan of Arrangement with Fairfax
WINNIPEG, Manitoba–(BUSINESS WIRE)–Farmers Edge Inc. (“Farmers Edge” or the “Company”) (TSX: FDGE) announced today that the... Read more.
SAIC Board of Directors Declares Cash Dividend
RESTON, Va.–(BUSINESS WIRE)–Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared... Read more.